Nanotechnology Now - Press Release: NanoInk's Nano BioDiscovery Division Launches Contract Research Program

Home > Press > NanoInk's Nano BioDiscovery Division Launches Contract Research Program

Abstract:
New Program Offers an Extensive Assortment of Protein Array Services

NanoInk's Nano BioDiscovery Division Launches Contract Research Program

Skokie, IL | Posted on September 8th, 2009

NanoInk, Inc.®, a global leader in nanotechnology, is pleased to announce the launch of a Contract Research Program as part of its Nano BioDiscovery™ Division. Based on the patented Dip Pen Nanolithography® (DPN®) platform, NanoInk's contract services provide miniaturization and multiplex protein analysis. Drawing on NanoInk's expertise in array fabrication and protein analysis, the new contract research program includes a wide range of protein array services. Customers can choose from complete custom assay development and analysis projects to protein profiling work, to custom array printing.

Bruce Dudzik, NanoInk's Senior Director for Business Development, explained that the typical NanoInk Nano BioDiscovery assay development project begins with the client specifying proteins of interest. "Working in close consultation with the customer at each step of the process, NanoInk's dedicated Contract Research scientists then develop the custom assay protocol, fabricate the custom nanoarrays, conduct on-array assays, extract and analyze data, and develop a comprehensive final report that includes image files and raw data."

DPN technology is capable of depositing highly reproducible, submicron protein features in one sub-array and patterning as many as 96 sub-arrays per slide. As a result, NanoInk's Nano BioDiscovery protein array services deliver unmatched assay sensitivity, even with the smallest of sample sizes. Just as importantly, nanoscale protein arrays enable multi-parallel, high throughput analysis.

The Nano BioDiscovery Division provides a new era of array-based instrument systems and contract research services for nanoscale protein detection. By combing DPN nanofabrication technology with optimized substrates and next-generation detection systems for a total system solution, Nano BioDiscovery helps its customers address major proteomic challenges.

Please visit www.nanoink.net/NanoBio_about.htm or call (847) 679-3432 for more information on the Nano BioDiscovery Division and its Contract Research Program.

####

About NanoInk
NanoInk, Inc. is an emerging growth technology company specializing in nanometer-scale manufacturing and applications development for the life science and semiconductor industries. Using Dip Pen Nanolithography® (DPN®), a patented and proprietary nanofabrication technology, scientists are enabled to rapidly and easily create nanoscale structures from a wide variety of materials. This low cost, easy to use and scalable technique brings sophisticated nanofabrication to the laboratory desktop. Located in the new Illinois Science + Technology Park, north of Chicago, NanoInk currently has over 140 patents and applications filed worldwide and has licensing agreements with Northwestern University, Stanford University, University of Strathclyde, University of Liverpool, California Institute of Technology and the University of Illinois at Urbana-Champaign. For more information on products and services offered by NanoInk, Inc., see www.nanoink.net.

NanoInk, the NanoInk logo, Dip Pen Nanolithography and DPN are trademarks or registered trademarks of NanoInk, Inc.

For more information, please click here

Contacts:
Jennifer Jameson
Dresner Corporate Services
312-780-7241

David Gutierrez
Dresner Corporate Services
312-780-7204

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark: